|
|
|
|
|
|
|
|
|
|
Astrazeneca Pharma India Ltd.
|
|
|
|
|
|
|
|
|
BSE Code |
506820
|
|
ISIN Demat |
INE203A01020
|
|
Book Value (Rs) |
308.14
|
|
|
NSE Code |
ASTRAZEN
|
|
Dividend Yield % |
0.35
|
|
Market Cap(Rs Mn) |
229073.75
|
|
|
TTM PE(x) |
197.92
|
|
TTM EPS(Rs) |
46.30
|
|
Face Value (Rs) |
2
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Astrazeneca Pharma India - MNC |
|
Incorporation Year
|
11-07 1979
|
|
Registered Office
|
Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road, Bengaluru,
Karnataka-560045 .
|
|
ISINNO
|
INE203A01020
|
|
Phone
|
080 6774 8000
|
|
E-mail
|
comp.secy@astrazeneca.com |
|
URL
|
www.astrazenecaindia.com/india |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Shilpa Divekar Nirula
|
|
Managing Director
|
|
|
Company Secretary
|
Manasa R
|
|
Listing
|
BSE,NSE
|
|
|
|
|